PATENT CLAIM ANALYSIS

Application Number: 15906530
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "561000"]

Abstract:
Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.

Claim (Index 49):
The method of  claim 32 , wherein the decreasing the amount of beta-alanine ingested in a 24 hour period for a period of time is from 3 days to 8 weeks.

Metadata:
- Claim Count in Document: 128.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15476620', '14673556', '12231240', '13900244', '12806356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.823648019480227
- 35 USC 102 Novelty (BERT): 0.6931838457377052
- Combined Prediction Score: 0.8106016021059749
- Mean Citation Score: 710.1229780000001
- Max Citation Score: 781.6417
- Similarity Product: 679.6281723083854

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test